首页 > 最新文献

中华预防医学杂志最新文献

英文 中文
[Pathogenic investigation of human respiratory syncytial virus infection in kindergarten children in Tongzhou District, Beijing City in 2023]. [2023 年北京市通州区幼儿园儿童人呼吸道合胞病毒感染的病原学调查]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240126-00091
L Zou, C Zhang, L Tong, X Liu, J Ma, J G Wang, F Wang, X Gao, L Xi, J M Zhang

The study focused on individuals with influenza-like symptoms (fever, cough, sore throat, runny nose, and other respiratory symptoms) in three kindergartens in Tongzhou District, Beijing City, in April 2023. Nasopharyngeal swab specimens were collected, and real-time fluorescent quantitative PCR was used to detect common respiratory pathogens in the collected specimens. Positive specimens were subjected to sequencing analysis of the highly variable region of human respiratory syncytial virus (HRSV) G protein, homology analysis and phylogenetic tree analysis. A total of 25 fever cases were collected from 3 kindergartens, aged 3-8 years old, with an age M (Q1, Q3) of 4 (3.5, 5) years old. Ten confirmed cases of HRSV positive were screened and detected using the fluorescent quantitative PCR method, with a total detection rate of 40% (10/25). Typing identification and sequencing analysis confirmed that the main epidemic type was HRSV subtype B, which was highly homologous and closely related to previous epidemic strains in the region. Through pathogen investigation and analysis, it was preliminarily determined that this epidemic was dominated by HRSV subtype B.

研究主要针对2023年4月北京市通州区三所幼儿园中出现流感样症状(发热、咳嗽、咽痛、流鼻涕和其他呼吸道症状)的个体。采集鼻咽拭子标本,采用实时荧光定量 PCR 技术检测标本中的常见呼吸道病原体。对阳性标本进行人呼吸道合胞病毒(HRSV)G蛋白高变异区测序分析、同源性分析和系统发生树分析。从 3 所幼儿园共收集到 25 例发热病例,年龄为 3-8 岁,年龄 M(Q1,Q3)为 4(3.5,5)岁。采用荧光定量 PCR 方法筛选并检测出 10 例确诊的 HRSV 阳性病例,总检出率为 40%(10/25)。分型鉴定和测序分析证实,主要流行类型为B亚型HRSV,与该地区以往流行的毒株高度同源,关系密切。通过病原体调查和分析,初步确定此次疫情以 HRSV B 亚型为主。
{"title":"[Pathogenic investigation of human respiratory syncytial virus infection in kindergarten children in Tongzhou District, Beijing City in 2023].","authors":"L Zou, C Zhang, L Tong, X Liu, J Ma, J G Wang, F Wang, X Gao, L Xi, J M Zhang","doi":"10.3760/cma.j.cn112150-20240126-00091","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240126-00091","url":null,"abstract":"<p><p>The study focused on individuals with influenza-like symptoms (fever, cough, sore throat, runny nose, and other respiratory symptoms) in three kindergartens in Tongzhou District, Beijing City, in April 2023. Nasopharyngeal swab specimens were collected, and real-time fluorescent quantitative PCR was used to detect common respiratory pathogens in the collected specimens. Positive specimens were subjected to sequencing analysis of the highly variable region of human respiratory syncytial virus (HRSV) G protein, homology analysis and phylogenetic tree analysis. A total of 25 fever cases were collected from 3 kindergartens, aged 3-8 years old, with an age <i>M</i> (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) of 4 (3.5, 5) years old. Ten confirmed cases of HRSV positive were screened and detected using the fluorescent quantitative PCR method, with a total detection rate of 40% (10/25). Typing identification and sequencing analysis confirmed that the main epidemic type was HRSV subtype B, which was highly homologous and closely related to previous epidemic strains in the region. Through pathogen investigation and analysis, it was preliminarily determined that this epidemic was dominated by HRSV subtype B.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1150-1153"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological characteristics of human respiratory syncytial virus in Hubei Province from 2016 to 2023]. [2016-2023年湖北省人呼吸道合胞病毒流行病学特征]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240111-00044
Q L Yin, X Yu, X Li, B Fang, X L Zhang, M W Peng, G J Ye, L L Liu

Objective: To analyze the epidemiological characteristics of human respiratory syncytial virus (HRSV) in patients with acute respiratory infection (ARIs) in sentinel hospitals of the Hubei influenza surveillance network from 2016 to 2023. Methods: ARIs samples [including influenza-like cases (ILI) and severe acute respiratory infection (SARI)] were collected from influenza surveillance sentinel hospitals in Hubei Province from 2016 to 2023, and case information was collected. HRSV virus nucleic acid typing was performed by fluorescence quantitative PCR method, and the data were collated, plotted and analyzed. Results: From 2016 to 2023, 12 779 cases of ILI and 9 166 cases of SARI were collected. The positive rate of HRSV was the highest in<5 years of age group [15.77% (168/1 065)], among which the positive rate was the highest in 2 to 5 years of age group of ILI cases [13.60% (31/228)], and the positive rate was the highest in 0 to 2 years of age group of SARI cases [25.97% (60/231)] (all P values<0.001). The positive rate of HRSV in SARI cases was 2.31%-25.97%, higher than that in ILI cases (0-13.60%) (P=0.016). HRSV was prevalent in autumn and winter from 2016 to 2020 and in spring in 2023. Alternating epidemics of HRSV virus type A and B in Hubei Province from 2016 to 2023 (dominant epidemics of type B in 2016 and 2020; dominant epidemics of type A in 2017-2019 and 2023). Conclusion: SARI and ILI patients under five years old are the main infection groups of HRSV. The seasonal prevalence characteristics of HRSV in Hubei Province from 2016 to 2023 shift from autumn and winter to spring.

目的分析2016-2023年湖北省流感监测网络哨点医院急性呼吸道感染(ARI)患者中人呼吸道合胞病毒(HRSV)的流行病学特征。方法:收集2016年至2023年湖北省流感监测哨点医院的ARIs样本[包括流感样病例(ILI)和重症急性呼吸道感染(SARI)],并收集病例信息。采用荧光定量PCR方法进行HRSV病毒核酸分型,并对数据进行整理、绘图和分析。结果从2016年到2023年,共收集到12 779例ILI病例和9 166例SARI病例。其中,HRSV阳性率最高(P值P=0.016)。2016 年至 2020 年,HRSV 在秋冬季流行,2023 年在春季流行。2016年至2023年湖北省甲、乙型HRSV病毒交替流行(2016年和2020年乙型病毒优势流行;2017-2019年和2023年甲型病毒优势流行)。结论SARI和5岁以下ILI患者是HRSV的主要感染人群。2016-2023年湖北省HRSV的季节流行特征由秋冬季转向春季。
{"title":"[Epidemiological characteristics of human respiratory syncytial virus in Hubei Province from 2016 to 2023].","authors":"Q L Yin, X Yu, X Li, B Fang, X L Zhang, M W Peng, G J Ye, L L Liu","doi":"10.3760/cma.j.cn112150-20240111-00044","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240111-00044","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the epidemiological characteristics of human respiratory syncytial virus (HRSV) in patients with acute respiratory infection (ARIs) in sentinel hospitals of the Hubei influenza surveillance network from 2016 to 2023. <b>Methods:</b> ARIs samples [including influenza-like cases (ILI) and severe acute respiratory infection (SARI)] were collected from influenza surveillance sentinel hospitals in Hubei Province from 2016 to 2023, and case information was collected. HRSV virus nucleic acid typing was performed by fluorescence quantitative PCR method, and the data were collated, plotted and analyzed. <b>Results:</b> From 2016 to 2023, 12 779 cases of ILI and 9 166 cases of SARI were collected. The positive rate of HRSV was the highest in<5 years of age group [15.77% (168/1 065)], among which the positive rate was the highest in 2 to 5 years of age group of ILI cases [13.60% (31/228)], and the positive rate was the highest in 0 to 2 years of age group of SARI cases [25.97% (60/231)] (all <i>P</i> values<0.001). The positive rate of HRSV in SARI cases was 2.31%-25.97%, higher than that in ILI cases (0-13.60%) (<i>P</i>=0.016). HRSV was prevalent in autumn and winter from 2016 to 2020 and in spring in 2023. Alternating epidemics of HRSV virus type A and B in Hubei Province from 2016 to 2023 (dominant epidemics of type B in 2016 and 2020; dominant epidemics of type A in 2017-2019 and 2023). <b>Conclusion:</b> SARI and ILI patients under five years old are the main infection groups of HRSV. The seasonal prevalence characteristics of HRSV in Hubei Province from 2016 to 2023 shift from autumn and winter to spring.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1129-1134"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis]. [脾氨肽口服液防治季节性过敏性鼻炎的应用研究]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240131-00106
H Y Shi, K L Zheng, C E Fan, H J Cai, T T Ma, H Y Ning, H T Wang, J J Zhang, X Y Wang

Methods: A total of 392 patients with seasonal allergic rhinitis were selected from the population of the epidemiological investigation project of allergic diseases in Hohhot, Inner Mongolia. The project was led by Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, and assisted by Hohhot First Hospital from April to May 2023. The patients were randomly divided into a spleen aminopeptide group (296 cases) and control group (96 cases) at a ratio of 3∶1, and the enrollment period was from June 1 to 14, 2023. The treatment group was treated with spleen aminopeptide oral solution for 12 weeks starting from 4-6 weeks (±7 days) before the pollen dispersal period, while the control group was treated with a simulated agent of spleen aminopeptide oral solution. Both the treatment group and the control group were treated with oral antihistamines and/or nasal glucocorticoids as needed during the pollen dispersal period. Evaluate the therapeutic effect by comparing the symptom scores, drug scores and quality of life scores of the two groups, and detect the expression levels of cytokines in serum. Symptom scores, quality of life scores, drug scores and laboratory results were compared by independent sample t test/Kruskal-Wallis test and χ2 test/Fisher's exact test. Results: Compared with the control group, spleen aminopeptide treatment for 12 weeks significantly improved symptoms of nasal congestion [M(Q1,Q3):2(1, 2) vs. 2(1, 3), H=6.308, P<0.05], nasal itching [M(Q1,Q3):2(1, 2) vs. 2(1, 3), H=4.966, P<0.05], sneezing [M(Q1,Q3):2(1, 2) vs. 2(1, 3), H=5.245, P<0.05], runny nose [M(Q1,Q3):2(1, 2) vs. 2(1, 3), H=5.41, P<0.05] and tearing [M(Q1,Q3):1(0, 2) vs. 1(0, 3), H=4.664, P<0.05]. At 12 weeks of treatment, the scores of nasal symptoms and ocular symptoms in control group and experimental group were significantly increased compared with baseline (P<0.05). In experimental group, nasal congestion [M(Q1,Q3):1(0, 1) vs. 1(0, 2), H=4.042, P<0.05], eye itching/foreign body sensation/redness symptom scores [M(Q1,Q3):1(0, 2) vs. 1(0, 2), H=5.302, P<0.05] and total scores [M(Q1,Q3):4(-1, 9) vs. 5(0, 12.5), H=3.958, P<0.05] were significantly increased. The antihistamine drug score of the splenic peptide treatment group at 6 weeks were lower than that of the control group (H=4.232, P<0.05). After 12 weeks of treatment, the antihistamine drug score [M(Q1

研究方法从内蒙古呼和浩特市过敏性疾病流行病学调查项目人群中选取 392 例季节性过敏性鼻炎患者。该项目由首都医科大学附属北京世纪坛医院变态反应科牵头,呼和浩特市第一医院协助,时间为2023年4月至5月。患者按3∶1的比例随机分为脾氨肽组(296例)和对照组(96例),入组时间为2023年6月1日至14日。治疗组在花粉传播期前 4-6 周(±7 天)开始使用健脾氨肽口服液治疗 12 周,对照组使用健脾氨肽口服液模拟制剂治疗。在花粉传播期间,治疗组和对照组均根据需要口服抗组胺药和/或鼻用糖皮质激素。通过比较两组的症状评分、药物评分和生活质量评分,并检测血清中细胞因子的表达水平,评价治疗效果。通过独立样本 t 检验/Kruskal-Wallis 检验和 χ2 检验/Fisher's exact 检验比较症状评分、生活质量评分、药物评分和实验室结果。结果与对照组相比,脾氨肽治疗12周可明显改善鼻塞症状[M(Q1,Q3):2(1, 2) vs. M(Q1,Q3):2(1, 3), H2(1, 3), H=6.308, PM(Q1,Q3):2(1, 2) vs. 2(1, 3), H=4.966, PM(Q1,Q3):2(1, 2) vs. 2(1, 3), H=5.245, PM(Q1,Q3):2(1, 2) vs. 2(1, 3), H=5.41, PM(Q1,Q3):1(0, 2) vs. 1(0, 3), H=4.966.1(0, 3), H=4.664, PM(Q1,Q3):1(0, 1) vs. 1(0, 2), H=4.042, PM(Q1,Q3):1(0, 2) vs. 1(0, 2), H=5.302, PM(Q1,Q3):4(-1, 9) vs. 5(0, 12.5), H=3.958, PH=4.232, PM(Q1,Q3):10(0, 24) vs. 19(2, 36.5), H=6.67, PM(Q1,Q3):28.5(5, 77.5) vs. 46(6, 155.5), H=3.995, Pvs.0.85±1.67,H=10.08, Pvs.0.94±1.73,H=5.196, PConclusions:脾氨肽口服液早期治疗可明显改善季节性过敏性鼻炎患者的鼻部和眼部症状,减少发病期的药物使用,提高生活质量。它可能通过降低患者血清中 IL-17A 的表达水平而发挥免疫调节作用。研究目的对内蒙古呼和浩特市季节性过敏性鼻炎的预防和治疗进行研究,评估脾氨肽口服液对季节性过敏性鼻炎的预防和治疗效果,并探讨其相关机制。
{"title":"[Application study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis].","authors":"H Y Shi, K L Zheng, C E Fan, H J Cai, T T Ma, H Y Ning, H T Wang, J J Zhang, X Y Wang","doi":"10.3760/cma.j.cn112150-20240131-00106","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240131-00106","url":null,"abstract":"<p><p><b>Methods:</b> A total of 392 patients with seasonal allergic rhinitis were selected from the population of the epidemiological investigation project of allergic diseases in Hohhot, Inner Mongolia. The project was led by Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, and assisted by Hohhot First Hospital from April to May 2023. The patients were randomly divided into a spleen aminopeptide group (296 cases) and control group (96 cases) at a ratio of 3∶1, and the enrollment period was from June 1 to 14, 2023. The treatment group was treated with spleen aminopeptide oral solution for 12 weeks starting from 4-6 weeks (±7 days) before the pollen dispersal period, while the control group was treated with a simulated agent of spleen aminopeptide oral solution. Both the treatment group and the control group were treated with oral antihistamines and/or nasal glucocorticoids as needed during the pollen dispersal period. Evaluate the therapeutic effect by comparing the symptom scores, drug scores and quality of life scores of the two groups, and detect the expression levels of cytokines in serum. Symptom scores, quality of life scores, drug scores and laboratory results were compared by independent sample <i>t</i> test/Kruskal-Wallis test and <i>χ</i><sup>2</sup> test/Fisher's exact test. <b>Results:</b> Compared with the control group, spleen aminopeptide treatment for 12 weeks significantly improved symptoms of nasal congestion [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):2(1, 2) <i>vs.</i> 2(1, 3), <i>H</i>=6.308, <i>P</i><0.05], nasal itching [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):2(1, 2) <i>vs.</i> 2(1, 3), <i>H</i>=4.966, <i>P</i><0.05], sneezing [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):2(1, 2) <i>vs.</i> 2(1, 3), <i>H</i>=5.245, <i>P</i><0.05], runny nose [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):2(1, 2) <i>vs.</i> 2(1, 3), <i>H</i>=5.41, <i>P</i><0.05] and tearing [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):1(0, 2) <i>vs.</i> 1(0, 3), <i>H</i>=4.664, <i>P</i><0.05]. At 12 weeks of treatment, the scores of nasal symptoms and ocular symptoms in control group and experimental group were significantly increased compared with baseline (<i>P</i><0.05). In experimental group, nasal congestion [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):1(0, 1) <i>vs.</i> 1(0, 2), <i>H</i>=4.042, <i>P</i><0.05], eye itching/foreign body sensation/redness symptom scores [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):1(0, 2) <i>vs.</i> 1(0, 2), <i>H</i>=5.302, <i>P</i><0.05] and total scores [<i>M</i>(<i>Q</i><sub>1</sub>,<i>Q</i><sub>3</sub>):4(-1, 9) <i>vs.</i> 5(0, 12.5), <i>H</i>=3.958, <i>P</i><0.05] were significantly increased. The antihistamine drug score of the splenic peptide treatment group at 6 weeks were lower than that of the control group (<i>H</i>=4.232, <i>P</i><0.05). After 12 weeks of treatment, the antihistamine drug score [<i>M</i>(<i>Q</i><sub>1</su","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1219-1229"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Screening and evaluation of clinical predictors of type 2 diabetes mellitus with cognitive impairment]. [筛查和评估伴有认知障碍的 2 型糖尿病的临床预测因素]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240104-00016
Y L Liang, W Z Wei, Q Z Hou, K K Huang, J Z Liao, J Liao, B Yi

The present study aims to screen and evaluate the early clinical predictors for type 2 diabetes mellitus (T2DM) patients with mild cognitive impairment (MCI) and dementia in Hunan province. A cross-sectional study was conducted from May 2023 to October 2023 to collect data on long-term T2DM patients who settled in Hunan province and were treated in the Department of Geriatrology at Xiangya Hospital of Central South University. The patients were grouped according to the Montreal Cognitive Assessment (MoCA) scale. Basic patient information and multiple serum markers were collected, and differences between groups were compared using one-way ANOVA or Kruskal-Wallis (KW) tests. The multivariate logistic regression analysis was utilized to assess risk factors and Nomogram models were constructed. The logistic regression analysis showed that years of education and serum levels of 1, 5-AG were related factors for the progression of T2DM to T2DM with MCI, and body weight, years of education and FPN levels affected the progression of T2DM with MCI to T2DM with dementia. Based on this, two Nomogram risk prediction models were established. The area under the curve (AUC) of the Nomogram model predicting T2DM progression to T2DM combined with MCI was 0.741, and the AUC of the Nomogram model predicting T2DM combined with MCI progression to T2DM combined with dementia was 0.734. The calibration curves (DCA) of the two models in the training and validation sets were symmetrically distributed near the diagonal line, indicating that the models in the training and validation sets could match each other. In summary, body weight, years of education, and serum HDL-3, FPN, and 1, 5-AG levels are associated with the development of MCI and dementia in T2DM patients. The Nomogram models constructed based on these factors can predict the risk of MCI and dementia in T2DM patients, providing a basis for clinical decision-making.

本研究旨在筛查和评估湖南省2型糖尿病(T2DM)轻度认知障碍(MCI)和痴呆患者的早期临床预测因素。本研究于 2023 年 5 月至 2023 年 10 月进行了一项横断面研究,收集了定居在湖南省并在中南大学湘雅医院老年医学科接受治疗的长期 T2DM 患者的数据。根据蒙特利尔认知评估(MoCA)量表对患者进行分组。收集患者的基本信息和多种血清指标,采用单因素方差分析或 Kruskal-Wallis (KW) 检验比较组间差异。采用多变量逻辑回归分析评估风险因素,并构建了 Nomogram 模型。Logistic回归分析表明,受教育年限和血清中1,5-AG水平是T2DM进展为T2DM伴MCI的相关因素,体重、受教育年限和FPN水平影响T2DM伴MCI进展为T2DM伴痴呆。在此基础上,建立了两个 Nomogram 风险预测模型。预测 T2DM 发展为 T2DM 合并 MCI 的 Nomogram 模型的曲线下面积(AUC)为 0.741,预测 T2DM 合并 MCI 发展为 T2DM 合并痴呆的 Nomogram 模型的曲线下面积(AUC)为 0.734。训练集和验证集中两个模型的校准曲线(DCA)在对角线附近对称分布,表明训练集和验证集中的模型可以相互匹配。总之,体重、受教育年限、血清 HDL-3、FPN 和 1、5-AG 水平与 T2DM 患者 MCI 和痴呆的发生有关。基于这些因素构建的Nomogram模型可以预测T2DM患者发生MCI和痴呆症的风险,为临床决策提供依据。
{"title":"[Screening and evaluation of clinical predictors of type 2 diabetes mellitus with cognitive impairment].","authors":"Y L Liang, W Z Wei, Q Z Hou, K K Huang, J Z Liao, J Liao, B Yi","doi":"10.3760/cma.j.cn112150-20240104-00016","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240104-00016","url":null,"abstract":"<p><p>The present study aims to screen and evaluate the early clinical predictors for type 2 diabetes mellitus (T2DM) patients with mild cognitive impairment (MCI) and dementia in Hunan province. A cross-sectional study was conducted from May 2023 to October 2023 to collect data on long-term T2DM patients who settled in Hunan province and were treated in the Department of Geriatrology at Xiangya Hospital of Central South University. The patients were grouped according to the Montreal Cognitive Assessment (MoCA) scale. Basic patient information and multiple serum markers were collected, and differences between groups were compared using one-way ANOVA or Kruskal-Wallis (KW) tests. The multivariate logistic regression analysis was utilized to assess risk factors and Nomogram models were constructed. The logistic regression analysis showed that years of education and serum levels of 1, 5-AG were related factors for the progression of T2DM to T2DM with MCI, and body weight, years of education and FPN levels affected the progression of T2DM with MCI to T2DM with dementia. Based on this, two Nomogram risk prediction models were established. The area under the curve (AUC) of the Nomogram model predicting T2DM progression to T2DM combined with MCI was 0.741, and the AUC of the Nomogram model predicting T2DM combined with MCI progression to T2DM combined with dementia was 0.734. The calibration curves (DCA) of the two models in the training and validation sets were symmetrically distributed near the diagonal line, indicating that the models in the training and validation sets could match each other. In summary, body weight, years of education, and serum HDL-3, FPN, and 1, 5-AG levels are associated with the development of MCI and dementia in T2DM patients. The Nomogram models constructed based on these factors can predict the risk of MCI and dementia in T2DM patients, providing a basis for clinical decision-making.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1184-1190"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The combined application of oligoclonal bands in cerebrospinal fluid and IgG intrathecal synthesis indicators and biochemical markers in the diagnosis of multiple sclerosis]. [脑脊液中的寡克隆带和鞘内 IgG 合成指标与生化标记物在多发性硬化症诊断中的联合应用]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231212-00433
K L Chen, J C Jiang, W C Jiang, L J Wang, S W Li, Z W Liu, Y Y Gu, G J Zhang

Objective: To establish and verify a diagnostic model for distinguishing multiple sclerosis (MS) from other neurological diseases with similar symptoms by usingcerebrospinal fluid oligoclonal band (CSF-OCB)combined with IgG intrathecal synthesis indicators and biochemical markers. Methods: Multiple sclerosis (MS) patients admitted to the Neurology Department of Beijing Tiantan Hospital affiliated with Capital Medical University from January 2014 to December 2022 were selected as the case group, while patients with similar neurological symptoms were selected as the control group. Using the case-control study design, a retrospective analysis was conducted on the detection of age, gender, oligoclonal bands in cerebrospinal fluid, IgG intrathecal synthesis indicators and biochemical indicators for all study subjects. The differential diagnosis model was determined by the multiple logistic regression analysis, and the receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficiency of the differential diagnosis model for neurological diseases with similar symptoms to MS and other conditions. Results: This study included 167 patients in the case group and 335 patients in the control group, of which 128 patients in the case group and 265 patients in the control group were used to construct the model, and 39 patients in the case group and 70 patients in the control group were used for model validation. The differential diagnostic model constructed by a multivariate logistic regression model was Y=0.871×CSF-OCB-0.051×CSFprotein-0.231×CSFchloride+1.183×gender-0.036×LDH+35.770. The model showed that the area under the curve, sensitivity and specificity were respectively 0.916, 87.3% and 87.6%. The Delong test results showed that the diagnostic efficacy of the model was significantly different from OCB, IgG intrathecal synthesis indicators, and OCB combined with IgG intrathecal synthesis indicators (P<0.05). The new model validation showed that the actual diagnostic consistency rate for the MS group was 84.6%, while the actual diagnostic consistency rate for the control group was 90.0%. Conclusion: This study combines OCB, IgG intrathecal synthesis indicators, and biochemical indicators to establish a diagnostic prediction model for neurological diseases with similar clinical symptoms in MS. This model may have good differential diagnostic value and can better assist clinical diagnosis in the early stages of disease progression in MS patients.

目的利用脑脊液寡克隆带(CSF-OCB)结合鞘内 IgG 合成指标和生化标记物,建立并验证多发性硬化症(MS)与其他具有类似症状的神经系统疾病的诊断模型。研究方法选取2014年1月至2022年12月首都医科大学附属北京天坛医院神经内科收治的多发性硬化症(MS)患者为病例组,具有相似神经系统症状的患者为对照组。采用病例对照研究设计,对所有研究对象的年龄、性别、脑脊液寡克隆带、鞘内IgG合成指标及生化指标的检测情况进行回顾性分析。通过多元逻辑回归分析确定鉴别诊断模型,并利用接收器操作特征曲线(ROC)分析鉴别诊断模型对与多发性硬化症症状相似的神经系统疾病及其他疾病的诊断效率。研究结果本研究纳入了 167 例病例组患者和 335 例对照组患者,其中 128 例病例组患者和 265 例对照组患者用于构建模型,39 例病例组患者和 70 例对照组患者用于模型验证。通过多变量逻辑回归模型构建的鉴别诊断模型为:Y=0.871×CSF-OCB-0.051×CSFprotein-0.231×CSFchloride+1.183×性别-0.036×LDH+35.770。模型显示,曲线下面积、灵敏度和特异性分别为 0.916、87.3% 和 87.6%。Delong 检验结果显示,该模型的诊断效果与 OCB、鞘内 IgG 综合指标、OCB 结合鞘内 IgG 综合指标(PConclusion:本研究将 OCB、鞘内 IgG 综合指标和生化指标相结合,建立了多发性硬化临床症状相似的神经系统疾病诊断预测模型。该模型可能具有很好的鉴别诊断价值,能在多发性硬化症患者疾病进展的早期更好地辅助临床诊断。
{"title":"[The combined application of oligoclonal bands in cerebrospinal fluid and IgG intrathecal synthesis indicators and biochemical markers in the diagnosis of multiple sclerosis].","authors":"K L Chen, J C Jiang, W C Jiang, L J Wang, S W Li, Z W Liu, Y Y Gu, G J Zhang","doi":"10.3760/cma.j.cn112150-20231212-00433","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231212-00433","url":null,"abstract":"<p><p><b>Objective:</b> To establish and verify a diagnostic model for distinguishing multiple sclerosis (MS) from other neurological diseases with similar symptoms by usingcerebrospinal fluid oligoclonal band (CSF-OCB)combined with IgG intrathecal synthesis indicators and biochemical markers. <b>Methods:</b> Multiple sclerosis (MS) patients admitted to the Neurology Department of Beijing Tiantan Hospital affiliated with Capital Medical University from January 2014 to December 2022 were selected as the case group, while patients with similar neurological symptoms were selected as the control group. Using the case-control study design, a retrospective analysis was conducted on the detection of age, gender, oligoclonal bands in cerebrospinal fluid, IgG intrathecal synthesis indicators and biochemical indicators for all study subjects. The differential diagnosis model was determined by the multiple logistic regression analysis, and the receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficiency of the differential diagnosis model for neurological diseases with similar symptoms to MS and other conditions. <b>Results:</b> This study included 167 patients in the case group and 335 patients in the control group, of which 128 patients in the case group and 265 patients in the control group were used to construct the model, and 39 patients in the case group and 70 patients in the control group were used for model validation. The differential diagnostic model constructed by a multivariate logistic regression model was Y=0.871×CSF-OCB-0.051×CSFprotein-0.231×CSFchloride+1.183×gender-0.036×LDH+35.770. The model showed that the area under the curve, sensitivity and specificity were respectively 0.916, 87.3% and 87.6%. The Delong test results showed that the diagnostic efficacy of the model was significantly different from OCB, IgG intrathecal synthesis indicators, and OCB combined with IgG intrathecal synthesis indicators (<i>P</i><0.05). The new model validation showed that the actual diagnostic consistency rate for the MS group was 84.6%, while the actual diagnostic consistency rate for the control group was 90.0%. <b>Conclusion:</b> This study combines OCB, IgG intrathecal synthesis indicators, and biochemical indicators to establish a diagnostic prediction model for neurological diseases with similar clinical symptoms in MS. This model may have good differential diagnostic value and can better assist clinical diagnosis in the early stages of disease progression in MS patients.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1171-1176"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on antibody index in the diagnosis and treatment of central nervous system diseases]. [诊断和治疗中枢神经系统疾病的抗体指数研究进展]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231113-00338
S R Wu, Y F Wang, D D Li

Cerebrospinal fluid (CSF) laboratory tests are important for diagnosing central nervous system (CNS) diseases. Research on intrathecal immunoglobulin-related indexes has gradually attracted attention. The antibody index, which corrects for the effect of individual blood-brain barrier function on CSF antibody test results, is of great significance in the differential diagnosis, efficacy monitoring and prognostic assessment of CNS diseases. It is expected to become a new index for the diagnosis of CNS diseases. This article reviews the concept of antibody index and the research progress of differential diagnosis and treatment of various CNS diseases in order to provide references for the diagnosis, efficacy monitoring and disease progression assessment of CNS diseases.

脑脊液(CSF)实验室检测是诊断中枢神经系统(CNS)疾病的重要依据。鞘内免疫球蛋白相关指标的研究已逐渐引起人们的关注。抗体指数校正了个体血脑屏障功能对 CSF 抗体检测结果的影响,对中枢神经系统疾病的鉴别诊断、疗效监测和预后评估具有重要意义。它有望成为诊断中枢神经系统疾病的新指标。本文综述了抗体指标的概念以及各种中枢神经系统疾病鉴别诊断和治疗的研究进展,以期为中枢神经系统疾病的诊断、疗效监测和疾病进展评估提供参考。
{"title":"[Research progress on antibody index in the diagnosis and treatment of central nervous system diseases].","authors":"S R Wu, Y F Wang, D D Li","doi":"10.3760/cma.j.cn112150-20231113-00338","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231113-00338","url":null,"abstract":"<p><p>Cerebrospinal fluid (CSF) laboratory tests are important for diagnosing central nervous system (CNS) diseases. Research on intrathecal immunoglobulin-related indexes has gradually attracted attention. The antibody index, which corrects for the effect of individual blood-brain barrier function on CSF antibody test results, is of great significance in the differential diagnosis, efficacy monitoring and prognostic assessment of CNS diseases. It is expected to become a new index for the diagnosis of CNS diseases. This article reviews the concept of antibody index and the research progress of differential diagnosis and treatment of various CNS diseases in order to provide references for the diagnosis, efficacy monitoring and disease progression assessment of CNS diseases.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1197-1203"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of virus gene subtypes and drug resistance monitoring results of newly reported HIV/AIDS population in Anhui Province from 2020 to 2023]. [2020-2023年安徽省新报告艾滋病人群病毒基因亚型及耐药性监测结果分析]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240308-00198
Y Z Qin, Y L Shen, A W Liu, J J Wu, L F Miu, Q Fang, C X Shuai, L Jin

Objective: To investigate the genetic subtypes and drug resistance monitoring of newly reported human immunodeficiency virus (HIV) infection/AIDS virus in Anhui Province from 2020 to 2023. Methods: An observational design study was used to collect blood samples from patients diagnosed with HIV/AIDS in the AIDS Prevention and Control Department of Anhui Provincial Center for Disease Control and Prevention from January 2020 to December 2023.The HIV-1 pol gene was amplified by reverse transcription-nested PCR, and the genetic subtypes were identified by phylogenetic tree analysis using MEGA 7.0 software. The mutation sites of drug resistance were analyzed by the online software tool of Stanford University's HIV Drug resistance database. The influencing factors of drug resistance before treatment were analyzed by multivariate logistic analysis. Results: A total of 335 plasma samples were collected, and 332 HIV-1 pol gene sequences were obtained successfully. The main gene subtypes were CRF01-AE, accounting for 35.55% (118/332), followed by CRF07-BC, B and B+C types [29.22% (97/332), 11.74% (39/332), 9.93% (33/332)]. The total drug resistance rate before treatment was 30.12%(32/100), and the drug resistance rate of protease inhibitor (PIs) in HIV-1 was 6.33% (21/332). The drug resistance rate of nucleoside reverse transcriptase inhibitors (NRTI) before treatment was 6.33% (21/332). The drug resistance rate of non-nucleoside reverse transcriptase inhibitors (NNRTI) before treatment was 17.47% (58/332).The comparison of drug resistance rate of different drug types showed statistical significance (χ2=30.435, P<0.05).Among the 100 cases of drug resistance, the main mutation point of HIV-1 protease inhibitor was Q58E (21.00%), and the main mutation point of nucleoside reverse transcriptase inhibitor was M184V/I (6.00%). Non-nucleoside reverse transcriptase inhibitor resistance mutation points mainly K103N (22.00%).There were statistically significant differences in the starting time of antiviral therapy, the number of CD4+T cells at baseline and the drug resistance rate of gene subtypes (the chi-square values are respectively 24.152, 32.516, 11.652, P<0.05).Multivariate logistic analysis showed that the baseline CD4+T cell count was <200/μl, subtype B, subtype B+C, CRF01-AE subtype, CRF55-01B subtype and 01-BC subtype was the influential factor of drug resistance before treatment (the chi-square values are respectively 4.577, 8.202, 4.416, 5.206, 7.603 and 4.804, P<0.05). Conclusion: The newly reported HIV/AIDS population in Anhui Province from 2020 to 2023 has a variety of viral gene subtypes, and NNRTIs are the main types of drug resistance gene mutations before treatment. Attention should be paid to the number of baseline CD4+T cells, the duration of antiviral treatment, and the distribution of gene subtypes to reduce the drug resistance of HIV/AIDS

目的调查 2020 年至 2023 年安徽省新报告的人类免疫缺陷病毒(HIV)感染/艾滋病病毒的基因亚型和耐药性监测情况。方法采用观察性设计研究方法,采集2020年1月至2023年12月安徽省疾病预防控制中心艾滋病预防控制所确诊的HIV/AIDS患者血样,通过反转录巢式PCR扩增HIV-1 pol基因,采用MEGA 7.0软件进行系统发生树分析,确定基因亚型。利用斯坦福大学艾滋病毒耐药性数据库的在线软件工具分析了耐药性的突变位点。治疗前耐药性的影响因素采用多变量逻辑分析法进行分析。结果共采集 335 份血浆样本,成功获得 332 个 HIV-1 pol 基因序列。主要基因亚型为 CRF01-AE,占 35.55%(118/332),其次为 CRF07-BC、B 和 B+C 型[29.22%(97/332)、11.74%(39/332)、9.93%(33/332)]。治疗前的总耐药率为 30.12%(32/100),HIV-1 对蛋白酶抑制剂(PIs)的耐药率为 6.33%(21/332)。治疗前核苷类逆转录酶抑制剂(NRTI)的耐药率为 6.33%(21/332)。不同药物类型的耐药率比较具有统计学意义(χ2=30.435,基线 P+T 细胞和基因亚型的耐药率(chi-square 值分别为 24.152、32.516、11.652,P+T 细胞计数为 PC):2020-2023年安徽省新报告HIV/AIDS人群病毒基因亚型多样,NNRTIs是治疗前耐药基因突变的主要类型。治疗前应注意基线CD4+T细胞数量、抗病毒治疗时间、基因亚型分布等,以减少HIV/AIDS患者耐药。
{"title":"[Analysis of virus gene subtypes and drug resistance monitoring results of newly reported HIV/AIDS population in Anhui Province from 2020 to 2023].","authors":"Y Z Qin, Y L Shen, A W Liu, J J Wu, L F Miu, Q Fang, C X Shuai, L Jin","doi":"10.3760/cma.j.cn112150-20240308-00198","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240308-00198","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the genetic subtypes and drug resistance monitoring of newly reported human immunodeficiency virus (HIV) infection/AIDS virus in Anhui Province from 2020 to 2023. <b>Methods:</b> An observational design study was used to collect blood samples from patients diagnosed with HIV/AIDS in the AIDS Prevention and Control Department of Anhui Provincial Center for Disease Control and Prevention from January 2020 to December 2023.The HIV-1 pol gene was amplified by reverse transcription-nested PCR, and the genetic subtypes were identified by phylogenetic tree analysis using MEGA 7.0 software. The mutation sites of drug resistance were analyzed by the online software tool of Stanford University's HIV Drug resistance database. The influencing factors of drug resistance before treatment were analyzed by multivariate logistic analysis. <b>Results:</b> A total of 335 plasma samples were collected, and 332 HIV-1 pol gene sequences were obtained successfully. The main gene subtypes were CRF01-AE, accounting for 35.55% (118/332), followed by CRF07-BC, B and B+C types [29.22% (97/332), 11.74% (39/332), 9.93% (33/332)]. The total drug resistance rate before treatment was 30.12%(32/100), and the drug resistance rate of protease inhibitor (PIs) in HIV-1 was 6.33% (21/332). The drug resistance rate of nucleoside reverse transcriptase inhibitors (NRTI) before treatment was 6.33% (21/332). The drug resistance rate of non-nucleoside reverse transcriptase inhibitors (NNRTI) before treatment was 17.47% (58/332).The comparison of drug resistance rate of different drug types showed statistical significance (<i>χ</i><sup>2</sup>=30.435, <i>P</i><0.05).Among the 100 cases of drug resistance, the main mutation point of HIV-1 protease inhibitor was Q58E (21.00%), and the main mutation point of nucleoside reverse transcriptase inhibitor was M184V/I (6.00%). Non-nucleoside reverse transcriptase inhibitor resistance mutation points mainly K103N (22.00%).There were statistically significant differences in the starting time of antiviral therapy, the number of CD4<sup>+</sup>T cells at baseline and the drug resistance rate of gene subtypes (the chi-square values are respectively 24.152, 32.516, 11.652, <i>P</i><0.05).Multivariate logistic analysis showed that the baseline CD4<sup>+</sup>T cell count was <200/μl, subtype B, subtype B+C, CRF01-AE subtype, CRF55-01B subtype and 01-BC subtype was the influential factor of drug resistance before treatment (the chi-square values are respectively 4.577, 8.202, 4.416, 5.206, 7.603 and 4.804, <i>P</i><0.05). <b>Conclusion:</b> The newly reported HIV/AIDS population in Anhui Province from 2020 to 2023 has a variety of viral gene subtypes, and NNRTIs are the main types of drug resistance gene mutations before treatment. Attention should be paid to the number of baseline CD4<sup>+</sup>T cells, the duration of antiviral treatment, and the distribution of gene subtypes to reduce the drug resistance of HIV/AIDS","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1204-1212"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Knowledge, attitude and practices of adult vaccine among the staff of vaccination units in Shandong Province]. [山东省接种单位工作人员对成人疫苗的认识、态度和实践]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240305-00188
S L Hu, Y Yu, W Y Zhang, Y J Zhang, R P Li, A Q Xu, Z H Yang

In order to understand the knowledge, attitude and practice (KAP) of vaccination against influenza, pneumonia, human papillomavirus (HPV), herpes zoster (HZ), COVID-19, and hepatitis B among staff of vaccination units in Shandong Province, a sample survey was conducted among 797 staffs of adult vaccination units in 12 counties (cities and districts) of Shandong Province from August to September 2022. The results showed that the respondents had the highest total score of knowledge and attitude for the COVID-19 vaccine, with the M (Q1, Q3) of 23 (20, 25) and 10 (10, 10), respectively, and had the lowest score of knowledge and attitude for the herpes zoster vaccine, with the M (Q1, Q3) of 19 (15, 22) and 8 (8, 10), respectively. The vaccine-related knowledge point"vaccine applicable population"had the highest score, with the M (Q1,Q3) of 26 (23, 30). The "contraindications/adverse reactions" and "adverse reaction management" had the lowest score, with the M (Q1, Q3) of 24 (20, 29) and 24 (20, 28), respectively. About 89.71% of respondents received one adult vaccine within two years at least. The principal driver for vaccination of 53.58% of recipients was their understanding of vaccines, which was"it was necessary to receive the vaccine". About 66.00% of respondents who had not received any adult vaccine in the past two years had insufficient awareness of the necessity of vaccination and believed that they were in good health and did not need to receive it. In summary, the staff of adult vaccination units in Shandong Province have a poor understanding of the herpes zoster vaccine in terms of vaccines and a relatively poor understanding of"contraindications/adverse reaction and management"in adult vaccination knowledge points.

为了解山东省预防接种单位工作人员对流感、肺炎、人乳头瘤病毒(HPV)、带状疱疹(HZ)、COVID-19和乙肝疫苗接种的知识、态度和实践(KAP)情况,我们于2022年8月至9月对山东省12个县(市、区)成人预防接种单位的797名工作人员进行了抽样调查。结果显示,被调查者对COVID-19疫苗的知识和态度总分最高,M(Q1,Q3)分别为23(20,25)和10(10,10);对带状疱疹疫苗的知识和态度总分最低,M(Q1,Q3)分别为19(15,22)和8(8,10)。疫苗相关知识点 "疫苗适用人群 "得分最高,M(Q1,Q3)为 26(23,30)。禁忌症/不良反应 "和 "不良反应处理 "得分最低,M(Q1,Q3)分别为 24(20,29)和 24(20,28)。约 89.71% 的受访者至少在两年内接种过一次成人疫苗。53.58%的受访者接种疫苗的主要原因是他们对疫苗的理解,即 "有必要接种疫苗"。约 66.00%的受访者在过去两年中没有接种过任何成人疫苗,他们对接种疫苗的必要性认识不足,认为自己身体健康,不需要接种疫苗。综上所述,山东省成人预防接种单位的工作人员对带状疱疹疫苗在疫苗方面的了解较少,对成人预防接种知识点中 "禁忌症/不良反应及处理 "的了解相对较少。
{"title":"[Knowledge, attitude and practices of adult vaccine among the staff of vaccination units in Shandong Province].","authors":"S L Hu, Y Yu, W Y Zhang, Y J Zhang, R P Li, A Q Xu, Z H Yang","doi":"10.3760/cma.j.cn112150-20240305-00188","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240305-00188","url":null,"abstract":"<p><p>In order to understand the knowledge, attitude and practice (KAP) of vaccination against influenza, pneumonia, human papillomavirus (HPV), herpes zoster (HZ), COVID-19, and hepatitis B among staff of vaccination units in Shandong Province, a sample survey was conducted among 797 staffs of adult vaccination units in 12 counties (cities and districts) of Shandong Province from August to September 2022. The results showed that the respondents had the highest total score of knowledge and attitude for the COVID-19 vaccine, with the <i>M</i> (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) of 23 (20, 25) and 10 (10, 10), respectively, and had the lowest score of knowledge and attitude for the herpes zoster vaccine, with the <i>M</i> (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) of 19 (15, 22) and 8 (8, 10), respectively. The vaccine-related knowledge point\"vaccine applicable population\"had the highest score, with the <i>M (Q</i><sub>1</sub>,<i>Q</i><sub>3</sub><i>)</i> of 26 (23, 30). The \"contraindications/adverse reactions\" and \"adverse reaction management\" had the lowest score, with the <i>M (Q</i><sub>1</sub>, <i>Q</i><sub>3</sub><i>)</i> of 24 (20, 29) and 24 (20, 28), respectively. About 89.71% of respondents received one adult vaccine within two years at least. The principal driver for vaccination of 53.58% of recipients was their understanding of vaccines, which was\"it was necessary to receive the vaccine\". About 66.00% of respondents who had not received any adult vaccine in the past two years had insufficient awareness of the necessity of vaccination and believed that they were in good health and did not need to receive it. In summary, the staff of adult vaccination units in Shandong Province have a poor understanding of the herpes zoster vaccine in terms of vaccines and a relatively poor understanding of\"contraindications/adverse reaction and management\"in adult vaccination knowledge points.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1252-1255"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Distribution and antibiotic resistance analysis of Gram positive cocci in bloodstream infections in a hospital in Inner Mongolia]. [内蒙古某医院血流感染中革兰氏阳性球菌的分布及抗生素耐药性分析]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231120-00354
L L Tian, B B Xing, Y M Zhang, J P Zhao

To investigate the strain composition and drug resistance characteristics of G+(Gram positive cocci) cocci causing bloodstream infections in the People's Hospital of Inner Mongolia Autonomous Region in recent years and provide a basis for the empirical and rational use of drugs for the prevention and treatment of bloodstream infections caused by G+cocci. The strain composition and drug-resistant characteristics of G+cocci isolated from positive blood culture specimens sent to various departments of the Inner Mongolia Autonomous Region People's Hospital from January 2015 to December 2022 were retrospectively analyzed, and the higher detection rates of Staphylococcus hominis and Staphylococcus epidermidis, Enterococcus faecium and Enterococcus faecalis, and methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) were examined. MRSA and methicillin-sensitive Staphylococcus aureus (MSSA) were comparatively analyzed for resistance. The resistance data were analyzed by Whonet 5.6 statistical software, the significance of difference was analyzed by SPSS 22.0 software, and the resistance rate was compared by χ2 test. The results showed that 1 209 strains of G+cocci, in terms of the composition ratio, from high to low, were mainly human staphylococci (32.5%,393/1 209), Staphylococcus epidermidis (27.8%, 336/1 209), Staphylococcus aureus (14.9%,180/1 209) and Enterococcus faecalis (10.6%, 128/1 209). Among them, the detection rate of methicillin-resistant Staphylococcus aureus (MRSA) (42.8%, 77/180) was lower than that of methicillin-resistant coagulase-negative staphylococcus (MRCNS) (71.5%, 608/850); and among enterococci, the detection rate of Enterococcus faecalis (71.5%, 128/179) was much higher than that of Enterococcus faecalis (28.5%, 51/179). For drug resistance, the resistance rate to five commonly used antimicrobial drugs, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was higher in Staphylococcus hominis than in Staphylococcus epidermidis (χ2=7.152-64.080, P<0.05); however, for the aminoglycoside antimicrobial drug gentamicin, the rate of resistance in Staphylococcus humanus was lower than in Staphylococcus epidermidis, and the difference was statistically significant (χ2=11.895, P<0.05); no strains resistant to linezolid and vancomycin were found in both. Comparison of the resistance rates to seven antimicrobial drugs, gentamicin, rifampicin, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was significantly higher in MRSA than in MSSA (χ2=6.169-56.941, P<0.05); however, the resistance rate to cotrimoxazole, MRSA (15.6%, 12/77) was significantly lower than that of MSSA (35.3%, 36/102), and the difference was statistically significant (χ2=5.155, P<0.05); MRSA and MSSA resistant to

摘要】 目的 探讨近年来内蒙古自治区人民医院引起血流感染的G+(革兰阳性球菌)球菌的菌株组成及耐药特点,为防治G+球菌引起的血流感染的经验性合理用药提供依据。回顾性分析了2015年1月至2022年12月送往内蒙古自治区人民医院各科室血液培养阳性标本中分离出的G+球菌的菌株组成和耐药特征、并考察了人葡萄球菌和表皮葡萄球菌、粪肠球菌和粪肠球菌、耐甲氧西林金黄色葡萄球菌(MRSA)和甲氧西林敏感金黄色葡萄球菌(MSSA)的较高检出率。对 MRSA 和对甲氧西林敏感的金黄色葡萄球菌(MSSA)的耐药性进行了比较分析。耐药性数据采用 Whonet 5.6 统计软件进行分析,差异显著性采用 SPSS 22.0 软件进行分析,耐药率比较采用 χ2 检验。结果表明,1 209 株 G+occi 菌株中,从构成比来看,由高到低主要为人葡萄球菌(32.5%,393/1 209)、表皮葡萄球菌(27.8%,336/1 209)、金黄色葡萄球菌(14.9%,180/1 209)和粪肠球菌(10.6%,128/1 209)。其中,耐甲氧西林金黄色葡萄球菌(MRSA)的检出率(42.8%,77/180)低于耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)的检出率(71.5%,608/850);在肠球菌中,粪肠球菌的检出率(71.5%,128/179)远高于粪肠球菌(28.5%,51/179)。耐药性方面,同种葡萄球菌对环丙沙星、左氧氟沙星、莫西沙星、克林霉素和四环素五种常用抗菌药物的耐药率高于表皮葡萄球菌(χ2=7.152-64.080,Pχ2=11.895,P0.05);两者均未发现对利奈唑胺和万古霉素耐药的菌株。比较对庆大霉素、利福平、环丙沙星、左氧氟沙星、莫西沙星、克林霉素和四环素7种抗菌药物的耐药率,MRSA明显高于MSSA(χ2=6.169-56.941,Pχ2=5.155,P0.05);未发现对利奈唑胺和万古霉素耐药的MRSA和MSSA。粪肠球菌对青霉素G和氨苄西林的耐药率远高于粪肠球菌,差异有统计学意义(χ2=22.965,从血培养物中分离出的P+球菌为临床经验性合理用药提供依据,有效预防和降低G+球菌引起的血流感染发生率。
{"title":"[Distribution and antibiotic resistance analysis of Gram positive cocci in bloodstream infections in a hospital in Inner Mongolia].","authors":"L L Tian, B B Xing, Y M Zhang, J P Zhao","doi":"10.3760/cma.j.cn112150-20231120-00354","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231120-00354","url":null,"abstract":"<p><p>To investigate the strain composition and drug resistance characteristics of G<sup>+</sup>(Gram positive cocci) cocci causing bloodstream infections in the People's Hospital of Inner Mongolia Autonomous Region in recent years and provide a basis for the empirical and rational use of drugs for the prevention and treatment of bloodstream infections caused by G<sup>+</sup>cocci. The strain composition and drug-resistant characteristics of G<sup>+</sup>cocci isolated from positive blood culture specimens sent to various departments of the Inner Mongolia Autonomous Region People's Hospital from January 2015 to December 2022 were retrospectively analyzed, and the higher detection rates of Staphylococcus hominis and Staphylococcus epidermidis, Enterococcus faecium and Enterococcus faecalis, and methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) were examined. MRSA and methicillin-sensitive Staphylococcus aureus (MSSA) were comparatively analyzed for resistance. The resistance data were analyzed by Whonet 5.6 statistical software, the significance of difference was analyzed by SPSS 22.0 software, and the resistance rate was compared by <i>χ</i><sup>2</sup> test. The results showed that 1 209 strains of G<sup>+</sup>cocci, in terms of the composition ratio, from high to low, were mainly human staphylococci (32.5%,393/1 209), Staphylococcus epidermidis (27.8%, 336/1 209), Staphylococcus aureus (14.9%,180/1 209) and Enterococcus faecalis (10.6%, 128/1 209). Among them, the detection rate of methicillin-resistant Staphylococcus aureus (MRSA) (42.8%, 77/180) was lower than that of methicillin-resistant coagulase-negative staphylococcus (MRCNS) (71.5%, 608/850); and among enterococci, the detection rate of Enterococcus faecalis (71.5%, 128/179) was much higher than that of Enterococcus faecalis (28.5%, 51/179). For drug resistance, the resistance rate to five commonly used antimicrobial drugs, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was higher in Staphylococcus hominis than in Staphylococcus epidermidis (<i>χ</i><sup>2</sup>=7.152-64.080, <i>P</i><0.05); however, for the aminoglycoside antimicrobial drug gentamicin, the rate of resistance in Staphylococcus humanus was lower than in Staphylococcus epidermidis, and the difference was statistically significant (<i>χ</i><sup>2</sup>=11.895, <i>P<</i>0.05); no strains resistant to linezolid and vancomycin were found in both. Comparison of the resistance rates to seven antimicrobial drugs, gentamicin, rifampicin, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was significantly higher in MRSA than in MSSA (<i>χ</i><sup>2</sup>=6.169-56.941, <i>P</i><0.05); however, the resistance rate to cotrimoxazole, MRSA (15.6%, 12/77) was significantly lower than that of MSSA (35.3%, 36/102), and the difference was statistically significant (<i>χ</i><sup>2</sup>=5.155, <i>P<</i>0.05); MRSA and MSSA resistant to ","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1242-1246"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prediction of the clinical supply of blood components in Xi'an City from 2023 to 2025]. [2023-2025年西安市血液成分临床供应预测]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231226-00496
L H Zhang, J Wang, B Yao, X Y Chu, Z D Sun, C F Ma

Objective: To construct a prediction model for the clinical supply of blood components in Xi'an City from 2023 to 2025. Methods: Based on the blood supply data of the Blood Management Information System of Shaanxi Provincial Blood Center from January 2013 to December 2022, a gray prediction model and an exponential curve fitting model were used to construct the prediction model, and the optimal prediction model was determined according to the error parameters of the relevant indicators of the model. The supply of blood components in Xi'an from 2023 to 2025 was predicted. Results: The fitting equations of the exponential curve fitting model to predict the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were, x(1)t+1)=1.16e0.04tx(1)t+1)=1.04e0.12t and x(1)t+1)=1.01e1.10t, respectively. The mean absolute errors (mean relative errors) of the exponential curve fitting model in predicting the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were 10 488.7 (0.05%), 2 114.9 (0.08%) and 3 089.6 (0.07%), respectively, which were lower than those of the gray prediction model, about 10 488.7 (3.44%), 2 152.78 (8.20%) and 3 441.35 (7.92%), respectively. The exponential curve fitting model predicted that the clinical supply of blood components in Xi'an would increase year by year from 2023 to 2025, and the clinical supply of suspended red blood cells, platelets, and cryoprecipitate in Xi'an would increase to 409 467 U, 69 818 therapeutic volume and 94 724 U, respectively by 2025. Conclusion: The exponential curve fitting model can make a good prediction of the clinical supply of blood components in Xi'an City.

目的构建 2023-2025 年西安市血液成分临床供应预测模型。方法:根据陕西省血液中心 2013 年 1 月至 2025 年血液管理信息系统的血液供应数据,建立西安市 2023 年至 2025 年血液成分临床供应预测模型:根据陕西省血液中心血液管理信息系统2013年1月至2022年12月的血液供应数据,采用灰色预测模型和指数曲线拟合模型构建预测模型,并根据模型相关指标的误差参数确定最优预测模型。预测了 2023 年至 2025 年西安市血液成分供应量。预测结果预测西安市悬浮红细胞、血小板和低温沉淀供应量的指数曲线拟合模型的拟合方程为:x(1)(t+1)=1.16e0.04t,x(1)(t+1)=1.04e0.12t,x(1)(t+1)=1.01e1.10t。指数曲线拟合模型预测西安市悬浮红细胞、血小板和低温沉淀供应量的平均绝对误差(平均相对误差)分别为10 488.7(0.05%)、2 114.9(0.08%)和3 089.6(0.07%),分别低于灰色预测模型的10 488.7(3.44%)、2 152.78(8.20%)和3 441.35(7.92%)。指数曲线拟合模型预测西安市血液成分临床供应量从 2023 年到 2025 年将逐年增加,到 2025 年西安市悬浮红细胞、血小板和低温沉淀的临床供应量将分别增加到 409 467 U、69 818 治疗量和 94 724 U。结论指数曲线拟合模型可以很好地预测西安市血液成分的临床供应量。
{"title":"[Prediction of the clinical supply of blood components in Xi'an City from 2023 to 2025].","authors":"L H Zhang, J Wang, B Yao, X Y Chu, Z D Sun, C F Ma","doi":"10.3760/cma.j.cn112150-20231226-00496","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231226-00496","url":null,"abstract":"<p><p><b>Objective:</b> To construct a prediction model for the clinical supply of blood components in Xi'an City from 2023 to 2025. <b>Methods:</b> Based on the blood supply data of the Blood Management Information System of Shaanxi Provincial Blood Center from January 2013 to December 2022, a gray prediction model and an exponential curve fitting model were used to construct the prediction model, and the optimal prediction model was determined according to the error parameters of the relevant indicators of the model. The supply of blood components in Xi'an from 2023 to 2025 was predicted. <b>Results:</b> The fitting equations of the exponential curve fitting model to predict the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were, <i>x</i><sup>(1)</sup>(<i>t</i>+1)=1.16e<sup>0.04</sup><i><sup>t</sup></i>,<i>x</i><sup>(1)</sup>(<i>t</i>+1)=1.04e<sup>0.12</sup><i><sup>t</sup></i> and <i>x</i><sup>(1)</sup>(<i>t</i>+1)=1.01e<sup>1.10</sup><i><sup>t</sup></i>, respectively. The mean absolute errors (mean relative errors) of the exponential curve fitting model in predicting the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were 10 488.7 (0.05%), 2 114.9 (0.08%) and 3 089.6 (0.07%), respectively, which were lower than those of the gray prediction model, about 10 488.7 (3.44%), 2 152.78 (8.20%) and 3 441.35 (7.92%), respectively. The exponential curve fitting model predicted that the clinical supply of blood components in Xi'an would increase year by year from 2023 to 2025, and the clinical supply of suspended red blood cells, platelets, and cryoprecipitate in Xi'an would increase to 409 467 U, 69 818 therapeutic volume and 94 724 U, respectively by 2025. <b>Conclusion:</b> The exponential curve fitting model can make a good prediction of the clinical supply of blood components in Xi'an City.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 8","pages":"1213-1218"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华预防医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1